Login to Your Account

Pieris Getting $10M Up Front in Allergan Ophthalmology Deal

By Cormac Sheridan

Wednesday, September 23, 2009
Pieris AG is getting an up-front payment of $10 million from Allergan Inc., as part of a licensing deal under which the latter firm will gain access to its anticalin technology in ophthalmology indications. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription